Full View

GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications

JE Campbell, TD Müller, B Finan, RD DiMarchi… - Cell Metabolism - cell.com
The incretin system is an essential metabolic axis that regulates postprandial metabolism.
The two incretin peptides that enable this effect are the glucose-dependent insulinotropic …
被引用次数：44 相关文章
[HTML] sciencedirect.com

[HTML][HTML] GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications

JE Campbell, TD Müller, B Finan, RD DiMarchi… - Cell Metabolism, 2023 - Elsevier
The incretin system is an essential metabolic axis that regulates postprandial metabolism.
The two incretin peptides that enable this effect are the glucose-dependent insulinotropic …

GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications

JE Campbell, TD Müller, B Finan, RD DiMarchi… - Cell … - pubmed.ncbi.nlm.nih.gov
The incretin system is an essential metabolic axis that regulates postprandial metabolism.
The two incretin peptides that enable this effect are the glucose-dependent insulinotropic …

GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications.

JE Campbell, TD Müller, B Finan, RD DiMarchi… - Cell …, 2023 - europepmc.org
The incretin system is an essential metabolic axis that regulates postprandial metabolism.
The two incretin peptides that enable this effect are the glucose-dependent insulinotropic …